文献速递功能神经外科

局灶性皮质发育不良IIIa型对前颞叶内侧切除术治疗癫痫后发作结局的影响

Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.
PubMed 文献 · J Neurosurg · 2017-07-28

该回顾性分析纳入2011年6月至2014年4月在本机构接受前颞叶内侧切除术的51例颞叶癫痫患者,比较合并局灶性皮质发育不良IIIa型(FCD IIIa)与单纯海马硬化患者的发作结局。FCD IIIa组全部患者发作结局良好(Engel I或II级),而颞极无病理发现的患者中该比例为71%(p < 0.01)。作者认为经组织病理学证实的FCD IIIa患者术后发作结局显著优于单纯海马硬化患者。

要点

  • FCD IIIa组13例患者全部达到Engel I或II级良好发作结局。
  • 颞极无病理发现的患者中71%达到Engel I或II级(p < 0.01)。
  • 作者建议术前评估中努力检出FCD IIIa以选择合适切除技术并预测结局。

核心结论

  • 经组织病理学证实的FCD IIIa患者在前颞叶内侧切除术后的发作结局显著优于单纯海马硬化患者。
  • 作者认为术前评估中应进一步努力检出FCD IIIa,以便选择最合适的切除技术并为患者咨询预测术后发作结局。

研究设计与样本

  • 回顾性分析2011年6月至2014年4月在本机构接受前颞叶内侧切除术的全部颞叶癫痫患者。
  • 共51例颞叶癫痫患者接受前颞叶内侧切除术,其中13例诊断为FCD IIIa。
  • 通过组织病理学分析判定患者为海马硬化合并FCD I(即FCD IIIa)或单纯海马硬化,并比较两组年龄、性别、癫痫病程及Engel分级发作结局。

主要发现

  • 患者癫痫发作平均病程31.1年,术后平均随访18个月。
  • FCD IIIa组全部患者发作结局良好(Engel I或II级),而颞极无病理发现的患者中该比例为71%(p < 0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Temporal lobe epilepsy (TLE) is the most common type of pharmacoresistant focal epilepsy, for which anterior mesial temporal lobe resection (AMTLR) is a treatment option. Focal cortical dysplasia Type IIIa (FCD IIIa), a developmental lesion resulting from defects in neuronal formation and migration into the temporal pole (FCD I) combined with hippocampal sclerosis (HS), can be a neuropathological finding. In this study, the authors investigate the impact of FCD IIIa on seizure outcome in patients with TLE who underwent AMTLR. METHODS The authors performed a retrospective analysis of all patients with TLE who underwent AMTLR at their institution between June 2011 and April 2014. Histopathological analysis was used to determine whether patients had HS together with FCD I (FCD IIIa) or HS alone. The groups were compared with regard to age, sex, years of epilepsy, and seizure outcome using the Engel classification. RESULTS A total of 51 patients with TLE underwent AMTLR at the authors' institution. FCD IIIa was diagnosed in 13 cases. The patients experienced seizures for a mean duration of 31.1 years. The mean length of follow-up after the procedure was 18 months. All patients with FCD IIIa had a favorable seizure outcome (Engel Class I or II) compared with 71% of the patients with no pathological findings in the temporal pole (p < 0.01). CONCLUSIONS Patients with histopathologically proven FCD IIIa had a significantly better seizure outcome after AMTLR than patients with HS alone. Further effort should be made during presurgical evaluation to detect FCD IIIa so that the most suitable resection technique can be chosen and postoperative seizure outcome can be predicted for patient counseling.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Dührsen L, Sauvigny T, House PM, et al. Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy. J Neurosurg. 2017. PMID: 28753112. doi:10.3171/2017.2.JNS161295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。